Company Filing History:
Years Active: 2006
Title: David Harlan Singleton: Innovator in Sexual Dysfunction Treatments
Introduction
David Harlan Singleton, an inventive mind located in Noank, Connecticut, has made significant contributions to the field of pharmaceuticals, specifically targeting sexual dysfunction. With one patent to his name, Singleton has demonstrated a commitment to developing innovative solutions that address this critical health issue.
Latest Patents
Singleton's patent focuses on "Compounds for the treatment of sexual dysfunction." This groundbreaking patent includes polynucleotide and polypeptide sequences that are pivotal in the treatment of male erectile dysfunction (MED) and female sexual dysfunction (FSD), particularly female sexual arousal disorder (FSAD). The polypeptide sequences outlined in his patent involve various sequences that have been carefully engineered to enhance therapeutic outcomes.
Career Highlights
Throughout his career, Singleton has been associated with Pfizer Corporation, a leading pharmaceutical company known for its commitment to healthcare innovation. His work at Pfizer has positioned him at the forefront of research and development, allowing him to leverage the resources necessary to bring his ideas to fruition.
Collaborations
In his innovative journey, David Harlan Singleton has collaborated with prominent colleagues, including Neil Benson and Helen Frances Boyd. These partnerships have further enriched his research efforts and have contributed to the advancement of solutions targeting sexual dysfunction.
Conclusion
David Harlan Singleton stands as a noteworthy figure in the realm of pharmaceutical inventions. His dedication to developing compounds for the treatment of sexual dysfunction showcases not only his innovative spirit but also his commitment to improving the quality of life for countless individuals. With a strong foundation at Pfizer Corporation and essential collaborations, Singleton continues to pave the way for future innovations in healthcare.